Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. To revolutionise healthcare, Roche is investing heavily in R&D with CHF 11 billion in 2018. This is amongst the highest R&D spends in the world across all industries. Genentech, a member of the Roche Group, discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. We are a leading biotech company, with ~40 approved medicines and a promising development pipeline.